WallStreetZenWallStreetZen
NYSE: A

How to Buy Agilent Technologies Stock

Open Broker Account

Agilent Technologies Inc

Agilent Technologies is a diagnostic & research company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker A on the NYSE exchange.

Agilent Technologies stock last closed at $156.12, up 0.74% from the previous day, and has increased 5.34% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.28 percentage points. Agilent Technologies stock is currently +38.75% from its 52-week low of $112.52, and -4% from its 52-week high of $162.62.

There are currently 296.04M shares of A outstanding. The market cap of A is $46.22B. In the last 24 hours, 1.37M A shares were traded.

How to Buy Agilent Technologies Stock

Not sure how to invest in Agilent Technologies stock? Here's how.
  1. Choose where to buy Agilent Technologies stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Agilent Technologies stock.
  2. Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected. It's the best place to buy A stock.
  3. Deposit funds into your brokerage account: Choose your method of payment and add your info.
  4. Research Agilent Technologies stock: The Agilent Technologies ticker symbol is A. Is Agilent Technologies stock a good investment? Should you buy shares of A? How do A's underlying business fundamentals look? Do top analysts think Agilent Technologies is a good buy? Why has A's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if A is a good stock to buy).
  5. Place your A buy order: Decide if you will purchase A shares at the current market price or use a limit order to purchase A shares at a particular price.
  6. Get key alerts regarding your A position: Create a watchlist to key updates about your investment in Agilent Technologies shares.

Step 1: Choose where to buy Agilent Technologies stock

You need a brokerage account in order to access the NYSE market and buy A shares.

A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our analysis, eToro is the best online stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global markets: From Tech to Energy, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by signing up for an account with eToro today.

Open eToro Account

Step 2: Sign up for your brokerage account

Now that you've selected your brokerage, you'll need to fill out some personal details so you can invest in A today.

How to Create a New Investment Account on eToro

  1. Click here to get started.
  2. Input your personal details to open your new trading account.
  1. Send your info by pressing the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your brokerage account

Watch the walkthrough below if you need help depositing money into your brokerage account.

Get started with eToro today

Step 4: Research Agilent Technologies stock

It's critical to research stocks prior to buying, so you can understand the risk and opportunity.

Agilent Technologies shares quick numbers

A Price
$156.12
1w %
-0.54%
1y %
5.34%
5y %
127.28%
P/E
35.32x
P/B
9.08x
P/S
6.99x
PEG
2.36x
Revenue
$6.66B
Earnings
$1.33B
Fore. Rev. Growth
7.5%
Fore. Earn. Growth
16.61%
Market Cap
$46.22B
Next Earnings
N/A
Next Dividend
Jan 25, 2023

Fundamentals of Agilent Technologies

WallStreetZen was created to help average investors perform more in-depth fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on A's stock page.

Is A stock undervalued or overvalued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge A's true value.

Using relative valuations measures:

  • A could be undervalued based on its P/E ratio of 35.32x, relative to Diagnostics & Research industry P/E ratio of 36.45x
  • A may be overvalued based on its P/B ratio of 9.08x, relative to Diagnostics & Research industry P/B ratio of 4.48x
  • A may be overvalued based on its PEG ratio of 2.36x

You can do more valuation analysis on A's stock here.

Is A a healthy company?

Positive Health Checks:

  • There are more short-term assets than short-term liabilities on the A balance sheet.
  • A earnings of $1.58B is not sufficient to cover its interest payments.
  • There are more short-term assets than long-term liabilities on the A balance sheet.
  • A's operating cash flow of $1.31B allows it to safely service it's debt of $2.91B.
  • A profit margin has gone up from 16.1% to 19.9% in the past year.

Negative Health Checks:

  • A has a relatively high debt to equity ratio of 1.06.
  • Total A debt is higher than 5 years ago, relative to shareholder equity.

Is it a good time to buy Agilent Technologies stock?

Out of 9 Equities analysts who give ratings on A, the consensus analyst rating on A is a Buy

Should I buy or sell A stock?

Based on 9 analysts offering ratings for Agilent Technologies Inc.
Buy
Strong Buy
3 analysts 33.33%
Buy
3 analysts 33.33%
Hold
3 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Most Recent A Analyst Recommendations

Patrick B Donnelly, a top 4% analyst from Citigroup maintains A with a hold rating and raises their A price target from $145.00 to $150.00, on Nov 22, 2022.

Paul Knight, a top 13% analyst from KeyBanc maintains A with a strong buy rating and raises their A price target from $155.00 to $165.00, on Nov 22, 2022.

Puneet Souda, a bottom 2% analyst from SVB Leerink maintains A with a buy rating and raises their A price target from $145.00 to $160.00, on Nov 22, 2022.

Dan Leonard, a top 6% analyst from Credit Suisse initiates coverage on A with a buy rating and announces their A price target of $165.00, on Aug 25, 2022.

Derik De Bruin, a top 6% analyst from Bank of America maintains A with a strong buy rating and raises their A price target from $148.00 to $155.00, on Aug 17, 2022.

de Bruin raised his price target on Agilent Technologies, Inc. by 4.7% following the release of the company's Q3 2022 earnings report on 2022/08/16.

The company reported a beat in Q3 and management raised its FY 2022 guidance, the analyst summarized.

"His forecasts have moved higher and the peer group multiple has expanded," de Bruin added, accounting for his price target increase.

For Q3 2022, Agilent reported:

  • EPS of $1.34, which beat the Zacks Consensus Estimate of $1.20 by 11.7% and, by 21.8, Q3 2021's $1.10.
  • Revenue of $1.72B, which beat the Zacks Consensus Estimate by 4.85% and, by 8.2%, Q3 2021's $1.59B.
  • Life Sciences and Applied Markets Group revenue of $1.019B, a 14% increase Y/Y.
  • CrossLab Group revenue of $359M, a 5% increase Y/Y.
  • Diagnostics and Genomics Group revenue of $340M, a 2% decrease Y/Y.

Management guided:

For Q4 2022:

  • EPS of $1.38 to $1.40 which, if achieved, would beat the Zacks Consensus Estimate of $1.35.
  • Revenue of $1.75B to $1.775B which, if achieved, would be in line with the Zacks Consensus Estimate of $1.77B

For FY 2022:

  • EPS of $5.06 to $5.08 which, if achieved, would beat the Zacks Consensus Estimate of $4.88.
  • Revenue of $6.75B to $6.775B which, if achieved would beat the Zacks Consensus Estimate of $6.69B

Mike McMullen, President & CEO, commented: “The strong results in Q3, coupled with orders continuing to outpace revenues, highlight the ongoing strength and momentum of our diversified business. We have once again raised our full-year revenue and earnings outlook.” 

You can dig deeper into what analysts are projecting on the Agilent Technologies stock forecast page.

A Trading Indicators

SMA10
151.93
SMA20
146.99
SMA50
136.45
SMA100
133.33
SMA200
129.7
MACD
5.33
MACD Signal
4.96
MACD Histogram
0.37
RSI
64.83
Stochastic %K
81.33
Stochastic %D
79.31
StochRSI %K
34.35
StochRSI %D
39.25

A Growth Numbers

Last year, A earnings were $1.33B. In the past five year, A's earnings have grown by 17.54% per year. This was slower than the Diagnostics & Research industry average of 21.97%.

Last year, A revenue was $6.66B. In the last 5 year, A's revenue has grown by 8.67% per year. This was slower than the Diagnostics & Research industry average of 16.46%.

You can research A's earnings and revenue performance here.

Who is buying/selling A?

In the last year, executives and large shareholders at A have bought more shares than they have sold.

Heidi Fields, Director of A, was the latest A insider to sell. They sold $566,482.04 worth of A shares on Nov 23, 2022.

Get more info about who owns A stock here.

Can I rely on A as an income stream?

Agilent Technologies pays a dividend of 0.54%, compared to the Diagnostics & Research industry's average dividend yield of 1.89%. If you owned $1,000 of A stock, you would have received $5.38 in the past 12 months.

Agilent Technologies dividend payments have consistently grown over the past decade but have not remained stable.

Dig into more data about Agilent Technologies dividend yield and history here.

What others are saying about A

One of the reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Place your A buy order

You have two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are mostly the easiest way to buy.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a particular dollar amount limit, use a limit order.

Click the Open button and your broker will place your order.

If you need more help buying stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Get key alerts regarding your A position

Now that you own some A stock, you'll want to stay up-to-date on your investment.

Create a watchlist to get notified of the latest news about your A stock.

A Feed

How to Buy Stock in Agilent Technologies

To summarize, here are the 6 steps to buy Agilent Technologies stock:

  1. Choose where to buy Agilent Technologies stock
  2. Sign up for your brokerage account
  3. Deposit funds into your brokerage account
  4. Research Agilent Technologies stock
  5. Place your A buy order
  6. Get key alerts regarding your A position

If you are looking for a online brokerage, eToro is our favorite venue.

Get Started with eToro Today

If you want to keep track of your new investment in Agilent Technologies, click the button below.

NYSE: A
$156.12+1.14 (+0.74%)
Updated Dec 1, 2022
Open eToro Account
NYSE: A
$156.12+1.14 (+0.74%)
Updated Dec 1, 2022
Open eToro Account

FAQ

How much does it cost to buy one Agilent Technologies share?

As of Dec 1, 2022, it costs $156.12 to buy one share of Agilent Technologies stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.641 shares of A.

Get Started with eToro Today

Is now a good time to buy Agilent Technologies stock?

According to 9 Wall Street analysts who monitor Agilent Technologies, their consensus recommendation is to buy Agilent Technologies stock.

What is the best way to buy Agilent Technologies stock?

The best way to buy Agilent Technologies stock is within a brokerage account on eToro.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.